MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 02-28-2026
Insulet Corporation Retained Earnings 2011-2026 | PODD
Retained earnings — this is the portion of a company’s net profit that has not been distributed to shareholders as dividends but remains at the company’s disposal for future use. It is also referred to as retained income or accumulated earnings.Possible uses include
- reinvestment in development (R&D, equipment, marketing)
- debt repayment
- acquisition of other companies
- creation of reserves for the future
A high level of retained earnings indicates that the company is in a growth phase, accumulating capital and prioritizing reinvestment over dividend payouts. Conversely, low or negative retained earnings may suggest either a generous dividend policy, in which all profits are distributed to shareholders, or ongoing losses that reduce the overall financial result.
The presence of retained earnings does not indicate that the company has available cash — it is solely an accounting figure reflecting the accumulated portion of net profit remaining after dividends have been paid. Therefore, it is important for investors to analyze not only the amount of retained earnings, but also how effectively it is used to develop the business, reduce debt, or build financial stability.
Annual Retained Earnings Insulet Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 287 M | 40.3 M | -378 M | -584 M | -650 M | -666 M | -672 M | -684 M | -707 M | -680 M | -652 M | -578 M | -527 M | -482 M | -441 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 287 M | -707 M | -491 M |
Quarterly Retained Earnings Insulet Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 186 M | 98.2 M | 75.7 M | 40.3 M | -60.4 M | -138 M | -326 M | -378 M | -481 M | -533 M | -560 M | -584 M | -601 M | -596 M | -561 M | -650 M | -679 M | -691 M | -666 M | -666 M | -649 M | -661 M | -675 M | -672 M | -672 M | -672 M | -672 M | -684 M | -684 M | -684 M | -684 M | -707 M | -707 M | -707 M | -707 M | -680 M | -680 M | -680 M | -680 M | -652 M | -652 M | -652 M | -652 M | -578 M | -578 M | -578 M | -578 M | -527 M | -527 M | -527 M | -527 M | -482 M | -482 M | -482 M | -482 M | -430 M | -430 M | -430 M | -430 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 186 M | -707 M | -532 M |
Retained Earnings of other stocks in the Medical devices industry
| Issuer | Retained Earnings | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-176 M | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-533 M | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
-581 M | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
-424 M | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
-303 M | - | -10.19 % | $ 1.99 M | USA |
 |
Bruker Corporation
BRKR
|
2.41 B | $ 38.78 | -1.25 % | $ 5.78 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-185 M | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
-600 M | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-40.5 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-514 M | - | - | $ 10.2 M | USA |
 |
Allied Healthcare Products
AHPI
|
-15.7 M | - | 3.58 % | $ 2.21 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-157 M | $ 8.15 | 4.22 % | $ 585 M |  Israel |
 |
Second Sight Medical Products
EYES
|
-122 M | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-633 M | $ 9.69 | 3.09 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
-337 M | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-82.6 M | $ 4.15 | 4.01 % | $ 155 M |  France |
 |
Electromed
ELMD
|
21.2 M | $ 24.26 | 1.17 % | $ 205 M | USA |
 |
CONMED Corporation
CNMD
|
589 M | $ 43.13 | -0.43 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
20 M | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
-421 M | - | -20.74 % | $ 369 K | USA |
 |
FONAR Corporation
FONR
|
-33.6 M | $ 18.51 | 0.05 % | $ 121 M | USA |
 |
AxoGen
AXGN
|
-307 M | $ 29.17 | -2.21 % | $ 1.34 B | USA |
 |
Apyx Medical Corporation
APYX
|
-54.4 M | $ 3.31 | 4.42 % | $ 115 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-374 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-70.6 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-56.2 M | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-119 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
-519 M | $ 0.53 | 0.68 % | $ 54.5 M | USA |
 |
Misonix, Inc.
MSON
|
-39.3 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-395 M | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
-304 M | $ 0.79 | -1.24 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
2.48 B | $ 183.14 | 0.27 % | $ 13.7 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-303 M | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
-46.8 M | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-802 M | $ 3.99 | 7.7 % | $ 845 M | USA |
 |
BIOLASE
BIOL
|
-317 M | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
49.8 B | $ 113.59 | 0.01 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
86.1 M | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-813 M | - | - | $ 217 M | USA |
 |
InMode Ltd.
INMD
|
969 M | $ 13.58 | -0.18 % | $ 878 M | Israel |
 |
BioSig Technologies
BSGM
|
-255 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
5.57 B | $ 72.75 | -1.49 % | $ 108 B | USA |
 |
IRadimed Corporation
IRMD
|
56.8 M | $ 105.22 | 0.89 % | $ 1.33 B | USA |
 |
IRIDEX Corporation
IRIX
|
-79 M | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
Helius Medical Technologies
HSDT
|
-160 M | $ 2.31 | 16.67 % | $ 1.4 M | USA |
 |
Alphatec Holdings
ATEC
|
-1.42 B | $ 13.05 | 0.23 % | $ 1.96 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
14.2 B | $ 85.73 | 0.55 % | $ 50.1 B | USA |